Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress.

Authors: Schleicher, Emily M; Galvan, Adri M; Imamura-Kawasawa, Yuka; Moldovan, George-Lucian; Nicolae, Claudia M

Published In Nucleic Acids Res, (2018 09 28)

Abstract: During carcinogenesis, cells are exposed to increased replication stress due to replication fork arrest at sites of DNA lesions and difficult to replicate genomic regions. Efficient fork restart and DNA repair are important for cancer cell proliferation. We previously showed that the ADP-ribosyltransferase PARP10 interacts with the replication protein proliferating cell nuclear antigen and promotes lesion bypass by recruiting specialized, non-replicative DNA polymerases. Here, we show that PARP10 is overexpressed in a large proportion of human tumors. To understand the role of PARP10 in cellular transformation, we inactivated PARP10 in HeLa cancer cells by CRISPR/Cas9-mediated gene knockout, and overexpressed it in non-transformed RPE-1 cells. We found that PARP10 promotes cellular proliferation, and its overexpression alleviates cellular sensitivity to replication stress and fosters the restart of stalled replication forks. Importantly, mouse xenograft studies showed that loss of PARP10 reduces the tumorigenesis activity of HeLa cells, while its overexpression results in tumor formation by non-transformed RPE-1 cells. Our findings indicate that PARP10 promotes cellular transformation, potentially by alleviating replication stress and suggest that targeting PARP10 may represent a novel therapeutic approach.

PubMed ID: 30032250 Exiting the NIEHS site

MeSH Terms: Animals; CRISPR-Cas Systems; Carcinogenesis/genetics*; Cell Division; Cell Line, Transformed; DNA Damage; DNA Replication; Female; Gene Knockout Techniques; HeLa Cells; Heterografts; Humans; Mice; Mice, Nude; Neoplasm Proteins/deficiency; Neoplasm Proteins/physiology*; Poly(ADP-ribose) Polymerases/deficiency; Poly(ADP-ribose) Polymerases/physiology*; Proto-Oncogene Proteins/deficiency; Proto-Oncogene Proteins/physiology*; Retinal Pigment Epithelium/cytology; Up-Regulation

to Top